Sulfate limitation increases specific plasmid DNA yield and productivity in E. coli fed-batch processes

Author:

Gotsmy MathiasORCID,Strobl Florian,Weiß Florian,Gruber Petra,Kraus Barbara,Mairhofer JuergenORCID,Zanghellini JürgenORCID

Abstract

AbstractPlasmid DNA (pDNA) is a key biotechnological product whose importance became apparent in the last years due to its role as a raw material in the messenger ribonucleic acid (mRNA) vaccine manufacturing process. In pharmaceutical production processes, cells need to grow in the defined medium in order to guarantee the highest standards of quality and repeatability. However, often these requirements result in low product titer, productivity, and yield. In this study, we used constraint-based metabolic modeling to optimize the average volumetric productivity of pDNA production in a fed-batch process. We identified a set of 13 nutrients in the growth medium that are essential for cell growth but not for pDNA replication. When these nutrients are depleted in the medium, cell growth is stalled and pDNA production is increased, raising the specific and volumetric yield and productivity. To exploit this effect we designed a three-stage process (1. batch, 2. fed-batch with cell growth, 3. fed-batch without cell growth). The transition between stage 2 and 3 is induced by sulfate starvation. Its onset can be easily controlled via the initial concentration of sulfate in the medium. We validated the decoupling behavior of sulfate and assessed pDNA quality attributes (supercoiled pDNA content) in E. coli with lab-scale bioreactor cultivations. The results showed an increase in supercoiled pDNA to biomass yield by 33% and an increase of supercoiled pDNA volumetric productivity by 13 % upon limitation of sulfate. In conclusion, even for routinely manufactured biotechnological products such as pDNA, simple changes in the growth medium can significantly improve the yield and quality. Graphical Abstract

Funder

enGenes Biotech GmbH

Baxalta Innovations GmbH, a part of Takeda companies

University of Vienna

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference75 articles.

1. Mairhofer J, Lara AR. Advances in host and vector development for the production of plasmid DNA vaccines, cancer vaccines. Berlin: Springer; 2014. p. 505–41.

2. European Medicines Agency. 2020. Comirnaty assessment report, https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf. Accessed 28 Jul 2022.

3. Schmidt A, Helgers H, Vetter FL, Juckers A, Strube J. Fast and flexible mRNA vaccine manufacturing as a solution to pandemic situations by adopting chemical engineering good practice-continuous autonomous operation in stainless steel equipment concepts. Processes. 2021;9:1874.

4. Ramamoorth M, Narvekar A. Non viral vectors in gene therapy-an overview. J Clin Diagnostic Res JCDR. 2015;9(1):GE01.

5. Cherng J-Y, Schuurmans-Nieuwenbroek N, Jiskoot W, Talsma H, Zuidam N, Hennink W, Crommelin D. Effect of DNA topology on the transfection efficiency of poly ((2-dimethylamino) ethyl methacrylate)-plasmid complexes. J Controll Release. 1999;60:343–53.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3